The FUS-DDIT3 protein acts as an abnormal transcription factor [10] and the development of myxoid liposarcomas is thus regarded as a consequence of deregulated FUS-DDIT3 target genes [8,9,11]. This evidence concerns the gene DDIT3 and myxoid liposarcoma.